Home NDC 73141-020 Rifabutin
Product NDC 73141-020
11-digit product format 731410020
Labeler code 73141
Product ID 73141-020_52e7cb84-1fe6-54ce-e063-6294a90aa4b1
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Rifabutin
Dosage form CAPSULE
Route ORAL
Labeler A2A Integrated Pharmaceuticals
Application ANDA212430
Marketing category ANDA
Marketing start 2026-05-15
Substance RIFABUTIN
Active strength 150 mg/1
Pharmacologic classes Rifamycin Antimycobacterial [EPC], Rifamycins [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A212430-001 RIFABUTIN RIFABUTIN 150MG CAPSULE / ORAL AB 2026-03-19
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A212430-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A212430-001 RIFABUTIN 150MG CAPSULE / ORAL AB 2026-03-19 84e616aacf4f…2026-08-18 06:07:40 2026-07 A212430-001 RIFABUTIN 150MG CAPSULE / ORAL AB 2026-03-19 caaa826d4ba7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A212430-001 RIFABUTIN 150MG CAPSULE / ORAL AB 2026-03-19 a50c72e98297…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2026-09-14 22:38:34 2026-08 A212430-001 AB 1 84e616aacf4f…2026-08-18 06:07:40 2026-07 A212430-001 AB 1 caaa826d4ba7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A212430-001 AB 1 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Rifabutin
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength RIFABUTIN 150 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1W306TDA6S Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 198200 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 73141-020-04 73141002004 100 CAPSULE in 1 BOTTLE (73141-020-04) 100 capsule 2026-05-15 No No Current